Trial record 1 of 1 for:    s1304
Previous Study | Return to List | Next Study

Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Southwest Oncology Group
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group Identifier:
First received: July 16, 2013
Last updated: August 18, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)